• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算可手术骨骼转移患者的生存情况:贝叶斯信念网络的应用。

Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network.

机构信息

Orthopaedic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.

出版信息

PLoS One. 2011;6(5):e19956. doi: 10.1371/journal.pone.0019956. Epub 2011 May 13.

DOI:10.1371/journal.pone.0019956
PMID:21603644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3094405/
Abstract

BACKGROUND

Accurate estimations of life expectancy are important in the management of patients with metastatic cancer affecting the extremities, and help set patient, family, and physician expectations. Clinically, the decision whether to operate on patients with skeletal metastases, as well as the choice of surgical procedure, are predicated on an individual patient's estimated survival. Currently, there are no reliable methods for estimating survival in this patient population. Bayesian classification, which includes bayesian belief network (BBN) modeling, is a statistical method that explores conditional, probabilistic relationships between variables to estimate the likelihood of an outcome using observed data. Thus, BBN models are being used with increasing frequency in a variety of diagnoses to codify complex clinical data into prognostic models. The purpose of this study was to determine the feasibility of developing bayesian classifiers to estimate survival in patients undergoing surgery for metastases of the axial and appendicular skeleton.

METHODS

We searched an institution-owned patient management database for all patients who underwent surgery for skeletal metastases between 1999 and 2003. We then developed and trained a machine-learned BBN model to estimate survival in months using candidate features based on historical data. Ten-fold cross-validation and receiver operating characteristic (ROC) curve analysis were performed to evaluate the BNN model's accuracy and robustness.

RESULTS

A total of 189 consecutive patients were included. First-degree predictors of survival differed between the 3-month and 12-month models. Following cross validation, the area under the ROC curve was 0.85 (95% CI: 0.80-0.93) for 3-month probability of survival and 0.83 (95% CI: 0.77-0.90) for 12-month probability of survival.

CONCLUSIONS

A robust, accurate, probabilistic naïve BBN model was successfully developed using observed clinical data to estimate individualized survival in patients with operable skeletal metastases. This method warrants further development and must be externally validated in other patient populations.

摘要

背景

准确估计预期寿命对于管理影响四肢的转移性癌症患者非常重要,有助于设定患者、家庭和医生的期望。临床上,是否对患有骨骼转移的患者进行手术以及手术方式的选择,取决于患者个体的预期生存。目前,对于这一患者群体,尚无可靠的方法来估计生存。贝叶斯分类,包括贝叶斯置信网络(BBN)建模,是一种统计方法,用于探索变量之间有条件的、概率性关系,以便使用观察数据估计结果的可能性。因此,BBN 模型越来越多地用于各种诊断中,将复杂的临床数据编码为预后模型。本研究旨在确定开发贝叶斯分类器以估计接受轴性和附肢骨骼转移手术患者生存的可行性。

方法

我们在机构拥有的患者管理数据库中搜索了 1999 年至 2003 年间接受骨骼转移手术的所有患者。然后,我们开发并训练了一个基于历史数据的机器学习 BBN 模型,使用候选特征来估计患者的生存时间(以月为单位)。采用十折交叉验证和接收者操作特征(ROC)曲线分析来评估 BNN 模型的准确性和稳健性。

结果

共纳入 189 例连续患者。3 个月和 12 个月生存模型的生存预测的一级预测因素不同。经过交叉验证,ROC 曲线下面积分别为 3 个月生存概率的 0.85(95%CI:0.80-0.93)和 12 个月生存概率的 0.83(95%CI:0.77-0.90)。

结论

成功地使用观察到的临床数据开发了一个强大、准确、概率性的贝叶斯朴素 BBN 模型,以估计可手术骨骼转移患者的个体化生存。该方法值得进一步开发,并需要在其他患者群体中进行外部验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/d6ecf5cb9530/pone.0019956.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/5486ab3d9742/pone.0019956.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/080f209f1d12/pone.0019956.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/d6ecf5cb9530/pone.0019956.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/5486ab3d9742/pone.0019956.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/080f209f1d12/pone.0019956.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de4a/3094405/d6ecf5cb9530/pone.0019956.g003.jpg

相似文献

1
Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network.估算可手术骨骼转移患者的生存情况:贝叶斯信念网络的应用。
PLoS One. 2011;6(5):e19956. doi: 10.1371/journal.pone.0019956. Epub 2011 May 13.
2
Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?用于骨转移生存估计的多变量模型(PATHFx)能否在日本患者中进行外部验证?
Clin Orthop Relat Res. 2017 Sep;475(9):2263-2270. doi: 10.1007/s11999-017-5389-3. Epub 2017 May 30.
3
External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.手术和非手术治疗有症状性骨转移患者中 PATHFx 版本 3.0 的外部验证。
Clin Orthop Relat Res. 2020 Apr;478(4):808-818. doi: 10.1097/CORR.0000000000001081.
4
External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.四肢骨转移手术治疗后生存预测的 SPRING 模型的外部验证和优化。
Clin Orthop Relat Res. 2018 Aug;476(8):1591-1599. doi: 10.1097/01.blo.0000534678.44152.ee.
5
Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?贝叶斯信念网络能否用于估计骨肉瘤患者的1年生存率?
Clin Orthop Relat Res. 2017 Jun;475(6):1681-1689. doi: 10.1007/s11999-017-5346-1. Epub 2017 Apr 10.
6
Treating metastatic disease: Which survival model is best suited for the clinic?治疗转移性疾病:哪种生存模型最适合临床?
Clin Orthop Relat Res. 2013 Mar;471(3):843-50. doi: 10.1007/s11999-012-2577-z.
7
External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases.对手术治疗的骨骼转移患者的贝叶斯估计生存工具(BETS)模型进行外部验证。
BMC Cancer. 2012 Oct 25;12:493. doi: 10.1186/1471-2407-12-493.
8
Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?我们能否估算接受转移性骨病手术患者的短期和中期生存率?
Clin Orthop Relat Res. 2017 Apr;475(4):1252-1261. doi: 10.1007/s11999-016-5187-3. Epub 2016 Dec 1.
9
A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network.四肢完全切除的高级软组织肉瘤的概率分析:贝叶斯信念网络的应用。
Ann Surg Oncol. 2012 Sep;19(9):2992-3001. doi: 10.1245/s10434-012-2345-z. Epub 2012 Apr 20.
10
How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.我们如何评估生存率?转移性骨病患者生存评估工具的外部验证——三个国际患者群体的决策分析与比较。
BMC Cancer. 2015 May 22;15:424. doi: 10.1186/s12885-015-1396-5.

引用本文的文献

1
Comparative Outcomes in Metastatic Spinal Cord Compression and Femoral Metastatic Disease: Distinct Clinical Entities with Divergent Prognoses?转移性脊髓压迫症与股骨转移性疾病的比较结果:不同的临床实体,预后不同?
Medicina (Kaunas). 2025 Jul 31;61(8):1390. doi: 10.3390/medicina61081390.
2
Validation of nine prognostic models in patients with bone metastases undergoing surgery.九种预后模型在接受手术的骨转移患者中的验证
J Orthop Surg Res. 2025 Aug 11;20(1):754. doi: 10.1186/s13018-025-06147-7.
3
Differential survival outcomes in upper versus lower extremity metastatic bone disease: a retrospective comparative cohort analysis.

本文引用的文献

1
Bayesian statistics in oncology: a guide for the clinical investigator.肿瘤学中的贝叶斯统计:临床研究者指南。
Cancer. 2009 Dec 1;115(23):5371-81. doi: 10.1002/cncr.24628.
2
Development of a clinical decision model for thyroid nodules.甲状腺结节临床决策模型的开发。
BMC Surg. 2009 Aug 10;9:12. doi: 10.1186/1471-2482-9-12.
3
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14.医生能否准确预测转移性癌症患者的生存时间?对放射治疗肿瘤学组97-14研究的分析。
上肢与下肢转移性骨病的不同生存结果:一项回顾性比较队列分析
J Orthop Surg Res. 2025 Jul 26;20(1):706. doi: 10.1186/s13018-025-06079-2.
4
Hospital-related healthcare expenditure of impending versus completed pathological femur fractures: a propensity score matched study of 265 patients.即将发生与已发生病理性股骨骨折的医院相关医疗保健支出:一项对265例患者的倾向评分匹配研究。
Acta Orthop. 2025 May 27;96:401-410. doi: 10.2340/17453674.2025.43479.
5
Artificial Intelligence in bone Metastases: A systematic review in guideline adherence of 92 studies.人工智能在骨转移中的应用:对92项研究指南依从性的系统评价
J Bone Oncol. 2025 Apr 24;52:100682. doi: 10.1016/j.jbo.2025.100682. eCollection 2025 Jun.
6
Artificial Intelligence and the State of the Art of Orthopedic Surgery.人工智能与骨外科手术的技术现状
Arch Bone Jt Surg. 2025;13(1):17-22. doi: 10.22038/ABJS.2024.84231.3829.
7
Systematic review of 99 extremity bone malignancy survival prediction models.99种肢体骨恶性肿瘤生存预测模型的系统评价。
J Orthop Traumatol. 2025 Jan 28;26(1):5. doi: 10.1186/s10195-025-00821-6.
8
Palliative care of proximal femur metastatic disease and osteolytic lesions: results following surgical and radiation treatment.股骨近端转移性疾病和溶骨性病变的姑息治疗:手术和放射治疗后的结果。
BMC Cancer. 2024 Nov 21;24(1):1431. doi: 10.1186/s12885-024-13170-0.
9
What Factors Are Associated With Implant Revision in the Treatment of Pathologic Subtrochanteric Femur Fractures?在病理性股骨转子下骨折的治疗中,哪些因素与植入物翻修相关?
Clin Orthop Relat Res. 2025 Mar 1;483(3):473-484. doi: 10.1097/CORR.0000000000003291. Epub 2024 Oct 22.
10
Risk Factors for Early Postoperative Morbidity and Mortality following Extremity Metastatic Pathologic or Impending Fracture Fixation.四肢转移性病理性或即将发生骨折固定术后早期术后发病率和死亡率的危险因素。
Int J Surg Oncol. 2024 Sep 12;2024:3565134. doi: 10.1155/2024/3565134. eCollection 2024.
J Palliat Med. 2008 Jun;11(5):723-8. doi: 10.1089/jpm.2007.0259.
4
Artificial neural networks estimating survival probability after treatment of choroidal melanoma.人工神经网络估计脉络膜黑色素瘤治疗后的生存概率。
Ophthalmology. 2008 Sep;115(9):1598-607. doi: 10.1016/j.ophtha.2008.01.032. Epub 2008 Mar 14.
5
Predictors of survival in patients with bone metastasis of lung cancer.肺癌骨转移患者生存的预测因素。
Clin Orthop Relat Res. 2008 Mar;466(3):729-36. doi: 10.1007/s11999-007-0051-0. Epub 2008 Jan 3.
6
Pathologic fractures correlate with reduced survival in patients with malignant bone disease.病理性骨折与恶性骨病患者生存率降低相关。
Cancer. 2007 Oct 15;110(8):1860-7. doi: 10.1002/cncr.22991.
7
Patient survival after surgery for osseous metastases from renal cell carcinoma.肾细胞癌骨转移手术后的患者生存率。
J Bone Joint Surg Am. 2007 Aug;89(8):1794-801. doi: 10.2106/JBJS.F.00603.
8
Prognostic factors in pathologic fractures secondary to metastatic tumors.转移性肿瘤继发病理性骨折的预后因素
Clinics (Sao Paulo). 2006 Aug;61(4):313-20. doi: 10.1590/s1807-59322006000400007.
9
Prediction of postoperative mortality in elderly patients with colorectal cancer.老年结直肠癌患者术后死亡率的预测
Dis Colon Rectum. 2006 Jun;49(6):816-24. doi: 10.1007/s10350-006-0523-4.
10
The use of artificial neural networks in decision support in cancer: a systematic review.人工神经网络在癌症决策支持中的应用:一项系统综述。
Neural Netw. 2006 May;19(4):408-15. doi: 10.1016/j.neunet.2005.10.007. Epub 2006 Feb 14.